A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Public ClinicalTrials.gov record NCT07553299. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Identify the Optimal Weekly Oral Dose of Ecnoglutide (VRB-101) for Maintaining Body Weight in Participants With Obesity or Overweight Who Have Weight-Related Comorbidities
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to identify the weekly oral dose of VRB-101 (oral ecnoglutide) that can effectively maintain body weight in participants with a history of obesity or overweight with weight-related comorbidities.
Study identification
- NCT ID
- NCT07553299
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2026 (Actual)
- Primary completion
- Sep 11, 2026 (Actual)
- Completion
- Sep 11, 2026 (Actual)
- Last update posted
- Oct 13, 2026
2026
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Study Site 202 | Cullman | Alabama | 35055 | — |
| Clinical Study Site 203 | Phoenix | Arizona | 85028 | — |
| Clinical Study Site 212 | Tempe | Arizona | 85281 | — |
| Clinical Study Site 201 | Little Rock | Arkansas | 72205 | — |
| Clinical Study Site 214 | Santa Maria | California | 93454 | — |
| Clinical Study Site 216 | Stamford | Connecticut | 06905 | — |
| Clinical Study Site 204 | Bradenton | Florida | 34209 | — |
| Clinical Study Site 221 | Orange City | Florida | 32763 | — |
| Clinical Study Site 215 | St. Petersburg | Florida | 33704 | — |
| Clinical Study Site 219 | Niles | Illinois | 60714 | — |
| Clinical Study Site 213 | El Dorado | Kansas | 67042 | — |
| Clinical Study Site 210 | Petal | Mississippi | 39465 | — |
| Clinical Study Site 205 | Buffalo | New York | 14217 | — |
| Clinical Study Site 206 | Lenoir | North Carolina | 28645 | — |
| Clinical Study Site 220 | Oklahoma City | Oklahoma | 73111 | — |
| Clinical Study Site 209 | Jackson | Tennessee | 38305 | — |
| Clinical Study Site 217 | Houston | Texas | 77008 | — |
| Clinical Study Site 211 | Houston | Texas | 77040 | — |
| Clinical Study Site 218 | Irving | Texas | 75063 | — |
| Clinical Study Site 207 | Richmond | Virginia | 23226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07553299, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07553299 live on ClinicalTrials.gov.